ES8405614A1 - Procedimiento de preparar farmacos con liberacion programada de materia activa. - Google Patents

Procedimiento de preparar farmacos con liberacion programada de materia activa.

Info

Publication number
ES8405614A1
ES8405614A1 ES500670A ES500670A ES8405614A1 ES 8405614 A1 ES8405614 A1 ES 8405614A1 ES 500670 A ES500670 A ES 500670A ES 500670 A ES500670 A ES 500670A ES 8405614 A1 ES8405614 A1 ES 8405614A1
Authority
ES
Spain
Prior art keywords
active substance
programmed release
procedure
preparing drugs
drugs
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES500670A
Other languages
English (en)
Spanish (es)
Other versions
ES500670A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pierre Fabre SA
Original Assignee
Pierre Fabre SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pierre Fabre SA filed Critical Pierre Fabre SA
Publication of ES500670A0 publication Critical patent/ES500670A0/es
Publication of ES8405614A1 publication Critical patent/ES8405614A1/es
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/48—Ergoline derivatives, e.g. lysergic acid, ergotamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ES500670A 1980-03-03 1981-03-03 Procedimiento de preparar farmacos con liberacion programada de materia activa. Expired ES8405614A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8004728A FR2477015A1 (fr) 1980-03-03 1980-03-03 Composition pharmaceutique a base d'un alcaloide de l'ergot de seigle, a activite regulatrice sur le tonus vasculaire

Publications (2)

Publication Number Publication Date
ES500670A0 ES500670A0 (es) 1984-07-01
ES8405614A1 true ES8405614A1 (es) 1984-07-01

Family

ID=9239246

Family Applications (1)

Application Number Title Priority Date Filing Date
ES500670A Expired ES8405614A1 (es) 1980-03-03 1981-03-03 Procedimiento de preparar farmacos con liberacion programada de materia activa.

Country Status (5)

Country Link
EP (1) EP0036350B1 (enExample)
AT (1) ATE5461T1 (enExample)
DE (1) DE3161526D1 (enExample)
ES (1) ES8405614A1 (enExample)
FR (1) FR2477015A1 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2539989B1 (fr) * 1983-01-28 1985-08-09 Sanofi Sa Medicament a liberation programmee associant l'acide acetylsalicylique a la dihydroergotamine
DK58983D0 (da) * 1983-02-11 1983-02-11 Leo Pharm Prod Ltd Farmaceutisk praeparat
DE3710216A1 (de) * 1987-03-27 1988-10-06 Rentschler Arzneimittel Verwendung von dihydroergotamin und seinen salzen zur lokalen behandlung trophischer stoerungen
GB9311191D0 (en) * 1993-05-29 1993-07-14 Danbiosyst Uk Controlled release drug formulation
AT408198B (de) * 1998-03-25 2001-09-25 Voest Alpine Ind Anlagen Verfahren zum stranggiessen eines dünnen bandes sowie vorrichtung zur durchführung des verfahrens
CN102266310B (zh) * 2011-07-21 2014-01-15 佛山市隆信医药科技有限公司 一种甲磺酸二氢麦角毒碱缓释胶囊及其制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3432593A (en) * 1963-09-18 1969-03-11 Key Pharm Inc Delayed and sustained release type pharmaceutical preparation
GB1443923A (en) * 1972-05-02 1976-07-28 Shepard M Sustained release compositions
DD146547A5 (de) * 1978-07-15 1981-02-18 Boehringer Sohn Ingelheim Arzneimittel-retardform mit unloeslichen poroesen diffusionshuellen
FR2453640A1 (fr) * 1979-04-12 1980-11-07 Labaz Compositions therapeutiques a usage oral et a liberation programmee du methanesulfonate de dihydroergotamine
FR2453642A1 (fr) * 1979-04-12 1980-11-07 Sanofi Sa Compositions therapeutiques a usage oral et a liberation programmee du methanesulfonate de dihydroergotoxine

Also Published As

Publication number Publication date
ATE5461T1 (de) 1983-12-15
FR2477015A1 (fr) 1981-09-04
ES500670A0 (es) 1984-07-01
DE3161526D1 (en) 1984-01-05
EP0036350B1 (fr) 1983-11-30
FR2477015B1 (enExample) 1983-06-10
EP0036350A1 (fr) 1981-09-23

Similar Documents

Publication Publication Date Title
AR224350A1 (es) Procedimiento para la obtencion de derivados de 1h-naft(2,3-d)imidazol
PL206826A1 (pl) Sposob wytwarzania nowych,optycznie czynnych pochodnych hydantoiny
NO153927C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 8-substituerte 4-amino-3-kinolinsyrederivater.
IT7825315A0 (it) Fenossi-benzil-ossicarbonilderivati sostituiti, procedimento per la loro preparazione e loro impiego come insetticidi e come acaricidi.
MX5934E (es) Procedimiento para la preparacion de 1-substituido-4,5-diaril-2-(tiosubstituido)imidazoles
MX144581A (es) Procedimiento para preparar colorantes de la serie del 3,7 difenil-2,6-dioxo-2,6-dihidrobenzo (1,2-b 4,5-b1)difurano
NL7709442A (nl) Werkwijze voor imidazo-(1,2-a)-chinoline-2- -carbonzuurderivaten.
NO148453C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive spirohydantoinderivater
NL182312B (nl) Werkwijze voor de bereiding van meerwaardige, aromatische cyaanzuuresters.
ES8405614A1 (es) Procedimiento de preparar farmacos con liberacion programada de materia activa.
DK545076A (da) Fremgangsmade til fremstilling af imidazolderivater
NL182313C (nl) Werkwijze voor de bereiding van meerwaardige, aromatische cyaanzuuresters.
AR217668A1 (es) Procedimiento de preparacion de derivados de tetrahidro-4,5,6,7-tieno-(2,3-c)-y-(3,2-c)-piridinas,utilizables como medicamentos
AR214971A1 (es) Procedimiento para la obtencion de derivados de 6-aril-pirrolo(1,2-a)-imidazol
IT1143757B (it) Composti ciclici derivati dal tiopene,procedimento per la loro preparazione e loro impiego farmaceutico
ES393914A0 (es) Procedimiento de preparacion de nuevos derivados de acido fenilacetico, racemicos, u opticamente activos
ES519743A0 (es) Procedimiento para la preparacion de derivados de corinanteina, asi como de sus sales de adicion acida fisiologicamente inocuas.
AR231536A1 (es) Procedimiento para la elaboracion de derivados del acido 5-o 6-alcanoil-,5-o 6-cicloalcanoil- y 5-o 6-benzoil-benzimidazol-2-carboxilico
ES465180A1 (es) Procedimiento para la preparacion de preparados de inmuno- globulinas
NO830900L (no) Fremgangsmaate for fremstilling av terapeutisk aktive tricykliske derivater.
AR218254A1 (es) Procedimiento para la preparacion de derivados del acido 2-metil-2-o 3-cefem-4-carboxilico 7-sustituido
NO167573C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive (5r, 6s,)-6-((r)-1-hydroksyetyl)-2-azacykloalkyltio-2-penem-3-karboksyl-syrederivater.
ES2070202T3 (es) Nuevos derivados de serina, procedimiento para su preparacion y su uso en terapia humana.
ES8609278A1 (es) Un procedimiento para la preparacion de analogos de benzodiazepina.
IT7825985A0 (it) Esteri dell'acido fosforico organici, procedimento per la loro preparazione e loro impiego come insetticidi, acaricidi e nematocidi.